<?xml version='1.0' encoding='utf-8'?>
<document id="21883747"><sentence text="A clinically significant interaction between tacrolimus and multiple proton pump inhibitors in a kidney transplant recipient."><entity charOffset="45-55" id="DDI-PubMed.21883747.s1.e0" text="tacrolimus" /></sentence><sentence text="The shared metabolism of PPIs and tacrolimus through the CYP enzyme system has been associated with clinically significant drug interactions, especially in patients who are classified as CYP 2C19 PMs"><entity charOffset="34-44" id="DDI-PubMed.21883747.s2.e0" text="tacrolimus" /></sentence><sentence text=" However, existing data are conflicting, indicating that a single mechanism does not account for all interactions" /><sentence text=" A drug interaction between tacrolimus and omeprazole, esomeprazole, but not lansoprazole, occurred in an 18-yr-old female kidney transplant recipient classified as a CYP 2C19 extensive (normal) metabolizer"><entity charOffset="28-38" id="DDI-PubMed.21883747.s4.e0" text="tacrolimus" /><entity charOffset="43-53" id="DDI-PubMed.21883747.s4.e1" text="omeprazole" /><entity charOffset="55-67" id="DDI-PubMed.21883747.s4.e2" text="esomeprazole" /><entity charOffset="77-89" id="DDI-PubMed.21883747.s4.e3" text="lansoprazole" /><pair ddi="false" e1="DDI-PubMed.21883747.s4.e0" e2="DDI-PubMed.21883747.s4.e0" /><pair ddi="false" e1="DDI-PubMed.21883747.s4.e0" e2="DDI-PubMed.21883747.s4.e1" /><pair ddi="false" e1="DDI-PubMed.21883747.s4.e0" e2="DDI-PubMed.21883747.s4.e2" /><pair ddi="false" e1="DDI-PubMed.21883747.s4.e0" e2="DDI-PubMed.21883747.s4.e3" /><pair ddi="false" e1="DDI-PubMed.21883747.s4.e1" e2="DDI-PubMed.21883747.s4.e1" /><pair ddi="false" e1="DDI-PubMed.21883747.s4.e1" e2="DDI-PubMed.21883747.s4.e2" /><pair ddi="false" e1="DDI-PubMed.21883747.s4.e1" e2="DDI-PubMed.21883747.s4.e3" /><pair ddi="false" e1="DDI-PubMed.21883747.s4.e2" e2="DDI-PubMed.21883747.s4.e2" /><pair ddi="false" e1="DDI-PubMed.21883747.s4.e2" e2="DDI-PubMed.21883747.s4.e3" /></sentence><sentence text=" This case suggests that further research is needed to establish the definitive mechanism of this potentially serious drug-drug interaction" /><sentence text=" Physicians prescribing PPIs in organ transplant recipients with tacrolimus immunosuppression should consider close pharmacokinetic monitoring of tacrolimus when starting or switching a PPI"><entity charOffset="65-75" id="DDI-PubMed.21883747.s6.e0" text="tacrolimus" /><entity charOffset="146-156" id="DDI-PubMed.21883747.s6.e1" text="tacrolimus" /><pair ddi="false" e1="DDI-PubMed.21883747.s6.e0" e2="DDI-PubMed.21883747.s6.e0" /><pair ddi="false" e1="DDI-PubMed.21883747.s6.e0" e2="DDI-PubMed.21883747.s6.e1" /></sentence><sentence text="" /></document>